Report title: Adprotech's lead drug candidate APT070, developed as treatment for rheumatoid arthritis and to improve organ transplant performance, will enter Phase II before end-2001
from Business & Industry®
66 word report published September 17, 2001

Price $9.95 available for immediate download HTML
Report Overview
Source: Marketletter
Geographic Region: European Union (EUCX), United Kingdom (UNK), Western Europe (WEEX)
Industry(ies): Pharmaceutical
Free Sample: Click Here to Download

 Business & Industry®
Business & Industry ® is a broad-based business information database which includes coverage from over 900 trade and business publications covering business events in over 190 countries around the world. B&I includes over 75 percent full-text coverage - the remaining records include informative abstracts which highlight the key information and facts discussed in the text. The Business & Industry database provides articles back to 1994.
Price: $9.95